← FDA Drug Approvals (Drugs@FDA)
CINQAIR
BLA · Biologics License Application · Sponsor: TEVA RESPIRATORY LLC · Approved 2016-03-23
Drug application
- FDA Application #
BLA761033- Application type
- Biologics License Application
- Brand name
- CINQAIR
- Generic name
- RESLIZUMAB
- Active ingredients
- RESLIZUMAB
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- TEVA RESPIRATORY LLC
- Manufacturer
- Teva Respiratory, LLC
- First approval
- 2016-03-23
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown